Chronic wounds represent a worldwide challenge, often proving difficult to heal with currently available treatments. This report introduces a novel tissue-engineered amniotic dressing, AmGel, used for treating chronic wounds in two patients. Prepared by integrating amniotic membrane with natural biopolymers, AmGel demonstrates excellent biocompatibility and safety, offering a safe, efficacious, and user-friendly therapeutic solution for chronic wounds. The aim of this study was to conduct a preliminary evaluation of the safety and effectiveness of this tissue-engineered amniotic dressing. Both patients achieved over an 80% wound healing rate within six weeks of treatment with AmGel, with complete wound closure occurring after twelve weeks. No adverse events were reported during the treatment period. This study describes the details of the clinical cases and provides an overview of the current evidence on the use of AmGel dressings in clinical practice.
Las HerasKIgartuaMSantos-VizcainoE, et al.Chronic wounds: Current status, available strategies and emerging therapeutic solutions. J Control Release. 2020;328:532‐550.
2.
FonderMALazarusGSCowanDA, et al.Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol. 2008;58(2):185‐206.
3.
Las HerasKGarcia-OrueIAguirreJJ, et al.Soy protein/β-chitin sponge-like scaffolds laden with human mesenchymal stromal cells from hair follicle or adipose tissue promote diabetic chronic wound healing. Biomater Adv. 2023;155:213682.
4.
TyebSVermaVKumarN. Polysaccharide based transdermal patches for chronic wound healing: Recent advances and clinical perspective. Carbohydr Polym. 2023;316:121038.
5.
WangSWZhangJZhouWL, et al.Injectable carrier hydrogel for diabetic foot ulcer wound repair. J Mater Sci. 2023;58(28):11441‐11468.
6.
FalconeMDe AngelisBPeaF, et al.Challenges in the management of chronic wound infections. J Glob Antimicrob Resist. 2021;26:140‐147.
7.
MengLGravesNDuRC, et al.Major limb amputation and mortality in patients with neuro-ischaemic lower extremity wounds managed in a tertiary hospital: Focus on the differences among patients with diabetes, peripheral arterial disease and both. Int Wound J. 2022;19(6):1298‐1308.
8.
MrugalaASuiAPlummerM, et al.Amniotic membrane is a potential regenerative option for chronic non-healing wounds: A report of five cases receiving dehydrated human amnion/chorion membrane allograft. Int Wound J. 2016;13(4):485‐492.
9.
MonikaPChandraprabhaMMurthyKC. Gene expression studies in primary human acute and chronic wound fibroblasts treated with most popular wound healing phytoextracts. S Afr J Bot. 2023;155:205‐213.
10.
PfisterPWendel-GarciaPDMeneauI, et al.Human amniotic membranes as an allogenic biological dressing for the treatment of burn wounds: Protocol for a randomized-controlled study. Contemp Clin Trials Commun. 2023;36:101209.
11.
Alsina-GibertMPedregosa-FausteS. Amniotic membrane transplantation in the treatment of chronic lower limb ulcers. Actas Dermosifiliogr. 2012;103(7):608‐613.
12.
ZhouZXXunJNWuCH, et al.Acceleration of burn wound healing by micronized amniotic membrane seeded with umbilical cord-derived mesenchymal stem cells. Materials Today Bio. 2023;20:100686.
13.
HuZMLuoYNiRH, et al.Biological importance of human amniotic membrane in tissue engineering and regenerative medicine. Materials Today Bio. 2023;22:100790.
14.
MamedeACCarvalhoMJAbrantesAM, et al.Amniotic membrane: From structure and functions to clinical applications. Cell Tissue Res. 2012;349(2):447‐458.
15.
LitwiniukMGrzelaT. Amniotic membrane: New concepts for an old dressing. Wound Repair Regen. 2014;22(4):451‐456.
16.
FaulkWPStevensPBurgosH, et al.Human amnion as an adjunct in wound healing. Lancet. 1980;315(8179):1156‐1158.
17.
SawhneyCP. Amniotic membrane as a biological dressing in the management of burns. Burns. 1989;15(5):339‐342.
18.
GholipourmalekabadiMMozafariMSalehiM, et al.Development of a cost-effective and simple protocol for decellularization and preservation of human amniotic membrane as a soft tissue replacement and delivery system for bone marrow stromal cells. Adv Healthcare Materials. 2015;4(6):918‐926.
19.
WilshawSPKearneyJNFisherJ, et al.Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng. 2006;12(8):2117‐2129.
20.
OesmanIDhamar HutamiW. Gamma-treated placental amniotic membrane allograft as the adjuvant treatment of unresponsive diabetic ulcer of the foot. Int J Surg Case Rep. 2020;66:313‐318.
21.
BianchiCCazzellSVayserD, et al.A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix®) allograft for the treatment of venous leg ulcers. Int Wound J. 2018;15(1):114‐122.
22.
LaveryLAFulmerJShebetkaKA, et al.The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: Results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J. 2014;11(5):554‐560.
23.
SnyderRJShimozakiKTallisA, et al.A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer. Wounds. 2016;28(3):70‐77.
